446. Tahaoglu К. The treatment of multidrug-resistant tuberculosis in
Turkey / K. Tahaoglu, T. Torun, T Sevim et al. // N. Engl. J. Med. - 2001. - Vol.
345, № 3 . - P. 170-174.
447. Tomokane Y. Clinical study on the effects of nizatidine on gastric
motility and cardiac autonomic function. Investigations using electrogastrography
and spectral analysis of heart rate variability / Y. Tomokane, M. Nomura, S.
Kujime et al. // Arzneimittelforschung. - 2004. - Vol. 54. - P. 427-435.
448. Tsakamura M. Antituberculosis chemotherapy including ofloxacin in
patients with pulmonary tuberculosis not treated previouslu / M. Tsakamura, S.
Yoshii, Y Yasuda et al. // Kekkaku. - 1986. - Vol. 61. - P. 15-17.
449. Tumbanatham A. Ofloxacin-induced artrhopathy in patients with
multidrug resistance tuberculosis / A. Tumbanatham, S. Vinodkuram //J. Assoc.
Physicians India. - 2000. - Vol. 48, № 6. - P. 647-648.
450.
Tumidge J. Pharmacocinetics and pharmacjdynamics of
fluoroquinolones / J. Tumidge // Drugs. - 1999. - Vol. 58, № 2. - P. 29-36.
451. Ungo J.R. Antituberculosis drug - induced hepatotoxity. The role of
hepatitis С virus and the human immunodeficiency virus / J.R. Ungo, D. Jones, D,
Ashkin et al. // Am. J. Respir. Crit. Care Med. - 1998. - Vol. 157, № 6. - P. 1871-
1876.
452. Uppal R. Adverse drug reactions among inpatients in a North Indian
referral hospital / R. Uppal, R. Jhaj, S. Malhotra // Nati Med. J. India. - 2000. -
Vol. 13, № l . - P . 16-18.
453. Volative markers of pulmonary tuberculosis in the breath / M. Philips
[et al.] // Europ. Resp. J. - 2004. - Vol. 28, Suppl. 48. - P. 2924.
454. Vybiral T. Conventional heart rate variability analysis of ambulatory
electrocardiographic recordings fails to predict imminent ventricular fibrillation /
T Vybiral [et al.] // J Am Coll Cardiol. - 1993. - Vol. 22. - P. 557-565.
455. Wada M. The adverse reactions of anti-tuberculosis drugs and its
management / M. Wada // Nippon Rinsho. - 1998. - Vol. 56, № 4. - P. 299-301.
404
